2011 - ISBTS 2011 Symposium


This page contains exclusive content for the member of the following sections: TTS, ITA. Log in to view.

Oral Communications 13: Biomarkers

15.247 - Serum albumin: a marker of intestinal mucosa recovery after exfoliative intestinal rejection

Presenter: Carolina, Rumbo, Buenos Aires, Argentina
Authors: Agustina Zambernardi1, Gabriel Gondolesi1, Martín Rumbo1, Ana Cabanne2, Maria Inés Martinez1, Hector Solar1, Carolina Rumbo1

247
Serum albumin: a marker of intestinal mucosa recovery after exfoliative intestinal rejection

Agustina Zambernardi1, Gabriel Gondolesi1, Martín Rumbo1, Ana Cabanne2, Maria Inés Martinez1, Hector Solar1, Carolina Rumbo1

1Instituto de Trasplante Multiorganico Unidad de Rehabilitación, Nutrición y Transplante Intestinal, Hospital Universitario - Fundación Favaloro, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina; 2Anatomia Patologica, Hospital Universitario - Fundación Favaloro, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Introduction: Exfoliative rejection (ExR) is a severe complication after intestinal transplant (ITx). The assessment and follow up of intestinal mucosa histology is restricted to a small area reached by endoscopy. There is no biochemical marker capable to reflect the total extension and severity of intestinal mucosa damage.  We aim to evaluate the value of serum albumin (SA) as a parameter of graft damage and recovery during ExR.

Patients and Methods: This is a retrospective review of ExR episodes in a cohort of ITx patients. The diagnosis of ExR was based on the histology criteria established in the “Pathology Workshop, VIIIth International Small Bowel Transplant Symposium, Miami, Florida”. Additional laboratory data and clinical variables (parenteral nutrition (PN) composition, use of albumin infusion, patient weight and infectious intercurrences, liver synthetic function, kidney function) were considered to rule out SA variations due to causes other than epithelial damage. SA levels were collected at least twice a week after the initial stabilization of the patient to avoid inaccurate values due to shock or dehydration. Clinical recovery (CR) was established when enteral nutrition was restarted and ostomy/stool output decreased to normal range (< 40 ml/kg/day in children and <1500 ml/day in adults). Histological recovery (HR) was considered after 2 consecutive normal biopsies.

Results: 7 episodes of ExR were diagnosed in 7/29 ITX recipients, (2 adults and 5 children). Four ExR episodes occurred early after transplant, while the patients were still admitted (GpA) and 3 in the ambulatory setting, more than 2 years after ITx (GpB). In both groups the SA reached a minimum average of 1.7g/dl (SD= 0.5) (normal values 3.5-5.2 g/dl), being lower in GpA (p<0.05). CR occurred in an average of 21 days in GpA and 41 days in GpB (p=0.08). The minimum time from diagnosis of ExR to normalization of SA levels was 30 days (GpA) and 60 days (GpB), except for one patient from GpB that remained dependent of PN, with subnormal values of SA level and was listed for re-transplantation. HR was reached in 32 days and 260 days for GpA and GpB respectively (p<0.02). In all cases normalization of SA occurred between CR and HR.

Conclusion: 1) SA might be used as a biochemical indicator of intestinal recovery during treatment of ExR. 2) SA seems to recover faster in early ExR and might be used as predictor of functional outcome. 


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada